Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
University of Chicago
Tubulis GmbH
Eli Lilly and Company
Merus B.V.
M.D. Anderson Cancer Center
University of Arizona
Betta Pharmaceuticals Co., Ltd.
Theravectys S.A.
Kidney Cancer Research Bureau
Perspective Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
VM Oncology, LLC
Takeda
BicycleTx Limited
Eli Lilly and Company
ITM Oncologics GmbH
University of Cincinnati
University of Arkansas
Maastricht University Medical Center
LigaChem Biosciences, Inc.
University of Kansas Medical Center
Coordination Pharmaceuticals, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
Providence Health & Services
National Institutes of Health Clinical Center (CC)
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Hoffmann-La Roche
West China Hospital
M.D. Anderson Cancer Center
Rapa Therapeutics LLC
Alume Biosciences, Inc.
GeoVax, Inc.
Intensity Therapeutics, Inc.
Fudan University
Alentis Therapeutics AG
PureTech
Psivac Ltd
BioAtla, Inc.